Ben Bartholomaeus, a former executive at Goldman Sachs, has been appointed by Citi as the Head of Healthcare for Australia and New Zealand within their Capital Markets and Advisory team. This key role will see Bartholomaeus drawing upon Citi’s global reach, industry knowledge, and execution proficiency to the benefit of its healthcare clientele in the Australasian region.
Bartholomaeus will operate out of Sydney and report to Philippe Perzi and Ben Connolly, the co-heads of Capital Markets and Advisory for Australia and New Zealand. Additionally, he will report to Ling Zhang, the Head of Healthcare for the Asia Pacific region.
Prior to this appointment, Bartholomaeus held the position of Head of Healthcare in the Corporate Advisory Division for Australia and New Zealand at Goldman Sachs.
Citi has an established reputation as a leading force in healthcare investment banking. It has retained its top position as a global advisor for mergers and acquisitions within the healthcare sector from 2024 through 2026 year-to-date. During this period, Citi has led major transactions for clients in various healthcare sectors including biopharma, medtech, and life science tools and diagnostics.
Who has Citi appointed as the new Head of Healthcare for Australia and New Zealand?
– Citi appointed Ben Bartholomaeus, a former Goldman Sachs executive, as the Head of Healthcare for Australia and New Zealand.
What role will Bartholomaeus be playing at Citi?
– Bartholomaeus will be responsible for bringing Citi’s global connectivity, sector insights, and execution expertise to healthcare clients in the Australasian region.
What is Citi’s standing in healthcare investment banking?
– Citi is a leader in healthcare investment banking. It has consistently secured the top rank as a global advisor for mergers and acquisitions in the healthcare sector from 2024 through 2026 year-to-date.
